The highly differentiated flu vaccine deltaFLUÂ®, developed by AVIR Green Hills Biotechnology, is a tailor-made influenza vaccine generated by reverse genetics. The necessity of preparation for a potential new influenza pandemic remains a widely debated issue among experts in the Vaccines industry. Worldwide on-going influenza research continues to find better ways to prevent, diagnose, and treat seasonal and pandemic influenza.
Dr. Thomas Muster, the CEO/CSO and co-founder of AVIR Green Hills Biotechnology, joined us at the World Influenza Congress in December 2011 as a speaker to share innovations in Virology, in particular with the deltaFLUÂ®, a replication-deficient intranasal influenza vaccine.
Why not download full details of his presentation and discover how to optimise the process for an attenuated influenza vaccine produced on vero cells:
Â· High yield production in Vero cells
Â· Induces mucosal and systemic immunity
Â· Rapid generation of vaccine virus
Â· Clinical trial results